Trademarkia Logo

Canada

C$
Circle Design
REGISTERED

on 23 Jul 2019

Last Applicant/ Owned by

AstraZeneca AB

Södertälje, SE-151 85

SE

Serial Number

1854638 filed on 28th Aug 2017

Registration Number

TMA1044038 registered on 23rd Jul 2019

Registration expiry Date

23rd Jul 2029

Correspondent Address

SMART & BIGGAR LP

Scotia Plaza, 40 King Street West40 th FloorToronto

ONTARIO

CA

M5H3Y2

Circle Design

Trademark usage description

pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases an Read More

Vienna Information


1 . 1 . 15

Comets, stars with tailComètes, étoiles avec queue

1 . 1 . 1

StarsÉtoiles

1 . 1 . 2

One starUne étoile

1 . 1 . 9

Stars with four pointsÉtoiles à quatre pointes

1 . 1 . 12

Stars with uneven points -- Note: Including sparks consisting of uneven-pointed stars.Étoiles à pointes irrégulières -- Note: Y compris les étincelles constituées d'étoiles à pointes irrégulières.

26 . 15 . 1

SpheresSphères

26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

26 . 1 . 13

Circles or ellipses containing representations of heavenly bodies or natural phenomenaCercles ou ellipses contenant la représentation de corps célestes ou de phénomènes naturels

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

Classification Information


Class [005]
Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective


Classification kind code

11

Mark Details


Serial Number

1854638

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 50
on 15th Mar 2019
Allowed
Submitted for opposition 42
on 28th Nov 2018
Advertised
Submitted for opposition 26
on 22nd Nov 2018
Approved
Submitted for opposition 27
on 4th Oct 2018
Approval Notice Sent
Submitted for opposition 15
on 3rd Oct 2018
Correspondence Created
Submitted for opposition 22
on 1st Oct 2018
Search Recorded
Submitted for opposition 20
on 1st Oct 2018
Examiner's First Report
Submitted for opposition 31
on 30th Aug 2017
Formalized
Submitted for opposition 30
on 28th Aug 2017
Filed
Submitted for opposition 1
on 28th Aug 2017
Created